-
Mashup Score: 0CPR Therapeutics Inc. Receives Three Patents In One Week For Innovations In Cardiopulmonary Resuscitation Technology - 9 month(s) ago
July 12, 2023 — CPR Therapeutics Inc. (CPR-T), a Vermont-based medical device start-up company, announced today that it has received three U.S. patents for inventions that will contribute to the development of their breakthrough technology for cardiopulmonary resuscitation. The first patent (US11,684,542) is for CPR devices that use more than one type of compression pattern to increase blood flow…
Source: DAICCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 0CMS proposes pathway to earlier breakthrough device coverage - 10 month(s) ago
The voluntary plan would allow manufacturers to address evidence gaps through studies designed to answer specific questions.
Source: MedTech DiveCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 2Breakthrough lung cancer pill slashes death risk by half - 10 month(s) ago
Researchers are calling the results of this decade-old study “thrilling” and “unprecedented”
Source: MediumCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 0Breakthrough: Physicists Discover That Gravity Can Create Light | Physics-Astronomy - 10 month(s) ago
In a groundbreaking discovery, physicists have found that gravity can create light under certain conditions, opening up new avenues of research in astrophysics and cosmology.
Source: Physics-Astronomy BlogCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 0Paradromics raises $33M, wins FDA breakthrough nod for brain-computer interface tech - 11 month(s) ago
Paradromics announced today that it raised $33 million in a Series A funding round and garnered an FDA breakthrough device designation.
Source: MassDeviceCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 0Ultromics secures FDA breakthrough device designation for cardiac AI - 12 month(s) ago
Ultromics has secured breakthrough device designation from the U.S. Food and Drug Administration (FDA) for its artificial intelligence (AI)-enhanced platform for detecting cardiac amyloidosis.
Source: AuntMinnie.comCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 0
Reach Neuro announced today that it received FDA breakthrough device designation for its Avantis platform for restoring movement.
Source: MassDeviceCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 0
A novel chimeric antigen receptor T-cell therapy induced clinically impactful antitumor responses in 63% of younger patients with relapsed or refractory, high-risk neuroblastoma, results of a phase 1/phase 2 trial showed.The findings, published in The New England Journal of Medicine, suggest the investigational agent also has a manageable safety profile similar to other CAR T-cell therapies,
Source: www.healio.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0
The bipartisan legislation, if enacted, would speed the coverage determination process for FDA-approved devices.
Source: MedTech DiveCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 1
Jim Allison: Breakthrough is the story of a Nobel Prize-winning immunologist who went from small-town Texas to taking on the medical establishment.
Source: Independent LensCategories: Hem/Oncs, Latest HeadlinesTweet
@DAICeditor #CPRTherapeutics Inc. announced that it has received three U.S. #patents for #inventions that will contribute to the development of their #breakthrough #technology for #cardiopulmonary #resuscitation: https://t.co/TlZub69umv